UZD Q1 2026 Earnings EPS Surges Past Estimates by Nearly 90 as Digital Infrastructure Demand Accelerates CBIO Q1 2026 Earnings Narrowed Loss Beats Expectations as Cash Management Remains Focus OUST Q1 2026 Earnings EPS Beat Drives Positive Market Reaction PRTA Q1 2026 Earnings Biotech Surprises with Positive EPS on Milestone Gain Stock Rises Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses GLDG Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline in PreRevenue Stage